
Expedia Rises, Sysco Falls, Viridian Therapeutics Tumbles as Eye Drug’s Efficacy Data Fall Short
Stock Movers
00:00
Viridian Falls After Thyroid Eye Data Miss
Isabelle Lee reports Viridian's stock tumble after late-stage efficacy data fell short of expectations.
Play episode from 03:15
Transcript


